MarginsXMarginsX
Home › Markets › Health Care › CING

Cingulate Inc. (CING)

CING trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.75
-12.79% on the day
Market cap
$54.5M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerCING on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2021
SEC CIK0001862150
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
16.5 months
$28.4M cash at June 30, 2026
Share count, 1 year
+121.4%
2025-11-11 to 2026-11-13 · +19063.0% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$657K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These uncertainties raise substantial doubt about our ability to continue as a going concern for one year after the issuance date of our financial statements."
10-Q 2026-11-13
Cash and burn$28.4M cash; operating cash flow -$5.2M a quarter.Report 2026-06-30
Shares outstanding14,963,080 (2026-11-13); 6,757,070 a year earlier; 18,740,006 three years earlier. 3y figure adjusted for splits (1-for-240 overall).Cover page 2026-11-13
Reverse splits, 3 years2; latest 1-for-12 on 2024-08-09Source 2024-08-09
Shelf and offerings, 12 months3 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-01-12
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKPMG LLP, Kansas City, Missouri, United StatesPCAOB Form AP 2026-04-20
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $657K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$5.9M-$5.9M$28.4M$5.1MNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$9.3M-$6.9M$25.9M$6.1MNeeds four quarters10-Q 2026-08-13
Q4 2025
2025-12-31
Not filed-$6.3M-$3.6M$11.0M$6.3MNeeds four quarters10-K 2026-03-18
Q3 2025
2025-09-30
Not filed-$7.3M-$4.2M$6.1M$3.2MNeeds four quarters10-Q 2025-11-13
Q2 2025
2025-06-30
Not filed-$5.0M-$4.8M$8.9M$5.1MNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$3.9M-$4.6M$9.5M$4.1MNeeds four quarters10-Q 2026-08-13
Q4 2024
2024-12-31
Not filed-$6.2M-$4.1M$12.2M$2.5MNeeds four quarters10-K 2026-03-18
Q3 2024
2024-09-30
Not filed-$4.1M-$3.9M$10.0MNo debt tagsNeeds four quarters10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-11-13
Latest annual report10-K2026-03-18
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-13
Latest proxyDEF 14A2026-05-29

Source: SEC EDGAR submissions feed, 497 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.9%
1 month-8.9%
3 months-13.8%
Year to date-0.9%
1 year+29.1%
From 52-week high-63.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
CINGWCingulate Inc. Warrants$0.0018

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
INCRIntercure Ltd.$3.63-4.22%$54.5M
AZRAzora Therapeutics Inc.$3.81-6.85%$54.4M
XLOXilio Therapeutics Inc.$7.70-3.08%$54.4M
VRCAVerrica Pharmaceuticals Inc.$3.20-10.11%$55.0M
HRTXHeron Therapeutics Inc.$0.2843-8.44%$54.1M
SPROSpero Therapeutics Inc.$0.9464-5.35%$55.1M
TNXPTonix Pharmaceuticals Holding Corp.$2.88-4.32%$56.0M
XBITXBiotech Inc.$1.85-5.37%$56.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier